Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:35:45-85.
doi: 10.1007/978-3-031-45493-6_4.

The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer

Gerald R Hankins  1 , Robert T Harris  2
Affiliations

The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer

Gerald R Hankins et al. Adv Neurobiol. 2024.

Abstract

It has become apparent that endogenous opioids act not only as neurotransmitters and neuromodulators, but have multiple functions in the body. Activation of the opioid system by opiate drugs is associated with a risk of cancer development through direct stimulation of tumor cell proliferation and through immunosuppression. In contrast, the endogenous peptide opioid [Met5]-enkephalin, now commonly referred to as Opioid Growth Factor (OGF), negatively regulates cell proliferation in a wide number of cells during development, homeostasis, and neoplasia. This action is mediated through the opioid growth factor receptor, originally designated the zeta (ζ) opioid receptor. Further, contrary to the traditional notion of opiates as immunosuppressive, endogenous OGF has been shown to possess a number of positive immunomodulatory properties and may provide a beneficial effect in cancer by augmenting the activity of cells involved in both innate and acquired immunity. Taken together, the evidence supports consideration of opioid peptides such as OGF as new strategies for cancer therapy.

Keywords: Cancer; Endogenous opioids; Immunology; Opioid growth factor.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Avella, D. M., Kimchi, E. T., Donahue, R. N., Tagaram, H. R. S., McLaughlin, P. J., Zagon, I. S., & Staveley-O’Carroll, K. F. (2010). The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. American Journal of Physiology Regulative, Intergrative and Comparitive Physiology, 298(2), 459–466. https://doi.org/10.1152/ajpregu.00646.2009 - DOI
    1. Bajpai, K., Singh, V. K., Agarwal, S. S., Dhawan, V. C., Naqvi, T., Haq, W., & Mathur, K. B. (1995). Immumodulatory activity of met-enkephelin and its two potent analogs. International Journal of Immunopharmacolcoy, 17(3), 207–212. https://doi.org/10.1016/0192-0561(94)00080-8 - DOI
    1. Bajpai, K., Singh, V. K., Dhawan, V. C., Haq, W., Mathur, K. B., & Agarwal, S. S. (1997). Immunomodulation by two potent analogs of met-enkephalin. Immunopharmacology, 35, 213–220. https://doi.org/10.1016/s0162-3109(96)00147-6 - DOI - PubMed
    1. Barron, B. A., Oakford, L. X., Gaugl, J. F., & Caffrey, J. L. (1995). Methionine-enkephalin-Arg-Phe immunoreactivity in heart tissue. Peptides, 16(7), 1221–1227. https://doi.org/10.1016/0196-9781(95)02012-l - DOI - PubMed
    1. Bisignani, G. J., McLaughlin, P. J., Ordille, S. D., Beltz, M. S., Jarowenko, M. V., & Zagon, I. S. (1999). Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor. The Journal of Urology, 162(2), 2186–2191. https://doi.org/10.1016/s0022-5347(05)68157-8 - DOI - PubMed

LinkOut - more resources